Holdings (Monthly)
Guide ↗
Virtus LifeSci Biotech Clinical Trials ETF
· ETFis Series Trust I| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | DGCXX | Jan 2026 | 1,165,588 | $1.2M | 3.17% | STIV |
| 2 | Erasca Inc | ERAS | Jan 2026 | 78,256 | $822K | 2.24% | EC |
| 3 | Corvus Pharmaceuticals Inc | CRVS | Jan 2026 | 33,658 | $697K | 1.90% | EC |
| 4 | Alumis Inc | ALMS | Jan 2026 | 24,519 | $601K | 1.64% | EC |
| 5 | Rezolute Inc | RZLT | Jan 2026 | 156,515 | $523K | 1.42% | EC |
| 6 | Ventyx Biosciences Inc | VTYX | Jan 2026 | 34,399 | $480K | 1.31% | EC |
| 7 | Enliven Therapeutics Inc | ELVN | Jan 2026 | 16,709 | $442K | 1.20% | EC |
| 8 | RAPT Therapeutics Inc | RAPT | Jan 2026 | 7,656 | $442K | 1.20% | EC |
| 9 | Intellia Therapeutics Inc | NTLA | Jan 2026 | 31,233 | $411K | 1.12% | EC |
| 10 | Ironwood Pharmaceuticals Inc | IRWD | Jan 2026 | 78,695 | $385K | 1.05% | EC |
| 11 | Tyra Biosciences Inc | TYRA | Jan 2026 | 12,450 | $384K | 1.04% | EC |
| 12 | CytomX Therapeutics Inc | CTMX | Jan 2026 | 67,237 | $383K | 1.04% | EC |
| 13 | Definium Therapeutics Inc | DFTX | Jan 2026 | 22,449 | $379K | 1.03% | EC |
| 14 | Structure Therapeutics Inc | GPCR | Jan 2026 | 4,201 | $372K | 1.01% | EC |
| 15 | CG oncology Inc | CGON | Jan 2026 | 6,880 | $358K | 0.97% | EC |
| 16 | Liquidia Corp | LQDA | Jan 2026 | 8,439 | $358K | 0.97% | EC |
| 17 | Dianthus Therapeutics Inc | DNTH | Jan 2026 | 6,688 | $357K | 0.97% | EC |
| 18 | Monte Rosa Therapeutics Inc | GLUE | Jan 2026 | 17,272 | $354K | 0.96% | EC |
| 19 | Immunome Inc | IMNM | Jan 2026 | 14,395 | $354K | 0.96% | EC |
| 20 | Annexon Inc | ANNX | Jan 2026 | 56,685 | $354K | 0.96% | EC |
| 21 | Tango Therapeutics Inc | TNGX | Jan 2026 | 30,131 | $350K | 0.95% | EC |
| 22 | Compass Therapeutics Inc | CMPX | Jan 2026 | 54,598 | $349K | 0.95% | EC |
| 23 | MBX Biosciences Inc | MBX | Jan 2026 | 9,436 | $348K | 0.95% | EC |
| 24 | Revolution Medicines Inc | RVMD | Jan 2026 | 3,570 | $346K | 0.94% | EC |
| 25 | Allogene Therapeutics Inc | ALLO | Jan 2026 | 186,572 | $343K | 0.93% | EC |
| 26 | Precigen Inc | PGEN | Jan 2026 | 76,349 | $343K | 0.93% | EC |
| 27 | Denali Therapeutics Inc | DNLI | Jan 2026 | 15,668 | $341K | 0.93% | EC |
| 28 | Vaxcyte Inc | PCVX | Jan 2026 | 6,332 | $339K | 0.92% | EC |
| 29 | GH Research PLC | GHRS | Jan 2026 | 21,612 | $338K | 0.92% | EC |
| 30 | Belite Bio Inc | BLTE | Jan 2026 | 1,993 | $337K | 0.92% | EC |
| 31 | Edgewise Therapeutics Inc | EWTX | Jan 2026 | 11,928 | $336K | 0.91% | EC |
| 32 | Praxis Precision Medicines Inc | PRAX | Jan 2026 | 1,047 | $329K | 0.89% | EC |
| 33 | uniQure NV | QURE | Jan 2026 | 14,441 | $328K | 0.89% | EC |
| 34 | Omeros Corp | OMER | Jan 2026 | 27,759 | $325K | 0.88% | EC |
| 35 | Upstream Bio Inc | UPB | Jan 2026 | 10,379 | $323K | 0.88% | EC |
| 36 | Oruka Therapeutics Inc | ORKA | Jan 2026 | 9,334 | $320K | 0.87% | EC |
| 37 | Engene Holdings Inc | ENGN | Jan 2026 | 33,300 | $317K | 0.86% | EC |
| 38 | Maze Therapeutics Inc | MAZE | Jan 2026 | 7,250 | $316K | 0.86% | EC |
| 39 | Pharvaris NV | PHVS | Jan 2026 | 11,661 | $315K | 0.86% | EC |
| 40 | Vir Biotechnology Inc | VIR | Jan 2026 | 42,110 | $313K | 0.85% | EC |
| 41 | ORIC Pharmaceuticals Inc | ORIC | Jan 2026 | 30,034 | $308K | 0.84% | EC |
| 42 | Amylyx Pharmaceuticals Inc | AMLX | Jan 2026 | 21,505 | $307K | 0.84% | EC |
| 43 | Arvinas Inc | ARVN | Jan 2026 | 22,396 | $300K | 0.82% | EC |
| 44 | Altimmune Inc | ALT | Jan 2026 | 53,460 | $299K | 0.81% | EC |
| 45 | MoonLake Immunotherapeutics | MLTX | Jan 2026 | 19,048 | $298K | 0.81% | EC |
| 46 | AnaptysBio Inc | ANAB | Jan 2026 | 6,268 | $297K | 0.81% | EC |
| 47 | Jade Biosciences Inc | JBIO | Jan 2026 | 18,807 | $294K | 0.80% | EC |
| 48 | Celcuity Inc | CELC | Jan 2026 | 2,677 | $293K | 0.80% | EC |
| 49 | Rocket Pharmaceuticals Inc | RCKT | Jan 2026 | 83,104 | $289K | 0.79% | EC |
| 50 | Xeris Biopharma Holdings Inc | XERS | Jan 2026 | 39,291 | $289K | 0.79% | EC |
| 51 | Biohaven Ltd | BHVN | Jan 2026 | 24,433 | $289K | 0.79% | EC |
| 52 | Viridian Therapeutics Inc | VRDN | Jan 2026 | 8,719 | $288K | 0.78% | EC |
| 53 | Tectonic Therapeutic Inc | TECX | Jan 2026 | 14,256 | $285K | 0.78% | EC |
| 54 | Beam Therapeutics Inc | BEAM | Jan 2026 | 10,298 | $284K | 0.77% | EC |
| 55 | Cytokinetics Inc | CYTK | Jan 2026 | 4,498 | $284K | 0.77% | EC |
| 56 | Cullinan Therapeutics Inc | CGEM | Jan 2026 | 23,635 | $283K | 0.77% | EC |
| 57 | AbCellera Biologics Inc | ABCL | Jan 2026 | 77,824 | $282K | 0.77% | EC |
| 58 | Compass Pathways Plc | CMPS | Jan 2026 | 41,800 | $280K | 0.76% | EC |
| 59 | Sionna Therapeutics Inc | SION | Jan 2026 | 6,587 | $278K | 0.76% | EC |
| 60 | Immunovant Inc | IMVT | Jan 2026 | 10,663 | $277K | 0.75% | EC |
| 61 | Nuvalent Inc | NUVL | Jan 2026 | 2,688 | $277K | 0.75% | EC |
| 62 | Arcus Biosciences Inc | RCUS | Jan 2026 | 13,085 | $275K | 0.75% | EC |
| 63 | Recursion Pharmaceuticals Inc | RXRX | Jan 2026 | 65,064 | $273K | 0.74% | EC |
| 64 | Inhibrx Biosciences Inc | INBX | Jan 2026 | 3,540 | $270K | 0.73% | EC |
| 65 | Kodiak Sciences Inc | KOD | Jan 2026 | 11,832 | $269K | 0.73% | EC |
| 66 | Relay Therapeutics Inc | RLAY | Jan 2026 | 35,085 | $269K | 0.73% | EC |
| 67 | Spyre Therapeutics Inc | SYRE | Jan 2026 | 8,380 | $268K | 0.73% | EC |
| 68 | Immatics NV | IMTX | Jan 2026 | 28,060 | $268K | 0.73% | EC |
| 69 | Arcellx Inc | ACLX | Jan 2026 | 3,919 | $268K | 0.73% | EC |
| 70 | Ideaya Biosciences Inc | IDYA | Jan 2026 | 8,280 | $267K | 0.73% | EC |
| 71 | Scholar Rock Holding Corp | SRRK | Jan 2026 | 6,011 | $267K | 0.73% | EC |
| 72 | Stoke Therapeutics Inc | STOK | Jan 2026 | 8,699 | $264K | 0.72% | EC |
| 73 | Xenon Pharmaceuticals Inc | XENE | Jan 2026 | 6,393 | $262K | 0.71% | EC |
| 74 | Prime Medicine Inc | PRME | Jan 2026 | 68,714 | $262K | 0.71% | EC |
| 75 | Dyne Therapeutics Inc | DYN | Jan 2026 | 14,621 | $262K | 0.71% | EC |
| 76 | Centessa Pharmaceuticals PLC | CNTA | Jan 2026 | 10,626 | $261K | 0.71% | EC |
| 77 | ArriVent Biopharma Inc | AVBP | Jan 2026 | 11,537 | $259K | 0.71% | EC |
| 78 | Septerna Inc | SEPN | Jan 2026 | 11,074 | $258K | 0.70% | EC |
| 79 | Bicara Therapeutics Inc | BCAX | Jan 2026 | 15,244 | $256K | 0.70% | EC |
| 80 | Janux Therapeutics Inc | JANX | Jan 2026 | 18,414 | $252K | 0.69% | EC |
| 81 | ProKidney Corp | PROK | Jan 2026 | 127,478 | $252K | 0.69% | EC |
| 82 | Celldex Therapeutics Inc | CLDX | Jan 2026 | 10,242 | $252K | 0.69% | EC |
| 83 | Zymeworks Inc | ZYME | Jan 2026 | 11,057 | $249K | 0.68% | EC |
| 84 | Rapport Therapeutics Inc | RAPP | Jan 2026 | 9,308 | $248K | 0.67% | EC |
| 85 | Arbutus Biopharma Corp | ABUS | Jan 2026 | 59,815 | $247K | 0.67% | EC |
| 86 | AtaiBeckley Inc | ATAI | Jan 2026 | 65,670 | $247K | 0.67% | EC |
| 87 | Vera Therapeutics Inc | VERA | Jan 2026 | 5,657 | $245K | 0.67% | EC |
| 88 | Nurix Therapeutics Inc | NRIX | Jan 2026 | 14,772 | $244K | 0.66% | EC |
| 89 | Sana Biotechnology Inc | SANA | Jan 2026 | 54,810 | $243K | 0.66% | EC |
| 90 | Bicycle Therapeutics PLC | BCYC | Jan 2026 | 37,816 | $243K | 0.66% | EC |
| 91 | Protagonist Therapeutics Inc | PTGX | Jan 2026 | 2,955 | $242K | 0.66% | EC |
| 92 | Rigel Pharmaceuticals Inc | RIGL | Jan 2026 | 6,909 | $241K | 0.66% | EC |
| 93 | MeiraGTx Holdings plc | MGTX | Jan 2026 | 31,584 | $240K | 0.65% | EC |
| 94 | Cogent Biosciences Inc | COGT | Jan 2026 | 6,690 | $240K | 0.65% | EC |
| 95 | Prothena Corp PLC | PRTA | Jan 2026 | 27,194 | $240K | 0.65% | EC |
| 96 | Apogee Therapeutics Inc | APGE | Jan 2026 | 3,655 | $239K | 0.65% | EC |
| 97 | EyePoint Inc | EYPT | Jan 2026 | 17,620 | $238K | 0.65% | EC |
| 98 | Neurogene Inc | NGNE | Jan 2026 | 13,466 | $238K | 0.65% | EC |
| 99 | Disc Medicine Inc | IRON | Jan 2026 | 3,068 | $237K | 0.65% | EC |
| 100 | Capricor Therapeutics Inc | CAPR | Jan 2026 | 10,827 | $237K | 0.64% | EC |
| 101 | Mineralys Therapeutics Inc | MLYS | Jan 2026 | 7,634 | $236K | 0.64% | EC |
| 102 | Newamsterdam Pharma Co NV | NAMS | Jan 2026 | 7,563 | $235K | 0.64% | EC |
| 103 | Keros Therapeutics Inc | KROS | Jan 2026 | 13,097 | $235K | 0.64% | EC |
| 104 | Fulcrum Therapeutics Inc | FULC | Jan 2026 | 21,670 | $233K | 0.63% | EC |
| 105 | Summit Therapeutics Inc | SMMT | Jan 2026 | 16,034 | $232K | 0.63% | EC |
| 106 | 4D Molecular Therapeutics Inc | FDMT | Jan 2026 | 25,989 | $230K | 0.63% | EC |
| 107 | Kymera Therapeutics Inc | KYMR | Jan 2026 | 3,141 | $228K | 0.62% | EC |
| 108 | Monopar Therapeutics Inc | MNPR | Jan 2026 | 3,775 | $228K | 0.62% | EC |
| 109 | REGENXBIO Inc | RGNX | Jan 2026 | 20,313 | $227K | 0.62% | EC |
| 110 | Viking Therapeutics Inc | VKTX | Jan 2026 | 7,597 | $221K | 0.60% | EC |
| 111 | WaVe Life Sciences Ltd | WVE | Jan 2026 | 17,012 | $220K | 0.60% | EC |
| 112 | Savara Inc | SVRA | Jan 2026 | 40,711 | $220K | 0.60% | EC |
| 113 | Taysha Gene Therapies Inc | TSHA | Jan 2026 | 48,657 | $219K | 0.60% | EC |
| 114 | Olema Pharmaceuticals Inc | OLMA | Jan 2026 | 8,524 | $219K | 0.60% | EC |
| 115 | Palvella Therapeutics Inc | PVLA | Jan 2026 | 2,857 | $219K | 0.60% | EC |
| 116 | Terns Pharmaceuticals Inc | TERN | Jan 2026 | 6,261 | $217K | 0.59% | EC |
| 117 | Lexeo Therapeutics Inc | LXEO | Jan 2026 | 28,837 | $214K | 0.58% | EC |
| 118 | Invivyd Inc | IVVD | Jan 2026 | 121,433 | $211K | 0.57% | EC |
| 119 | Soleno Therapeutics Inc | SLNO | Jan 2026 | 5,418 | $209K | 0.57% | EC |
| 120 | Xencor Inc | XNCR | Jan 2026 | 17,053 | $206K | 0.56% | EC |
| 121 | Assembly Biosciences Inc | ASMB | Jan 2026 | 7,804 | $201K | 0.55% | EC |
| 122 | Replimune Group Inc | REPL | Jan 2026 | 27,675 | $195K | 0.53% | EC |
| 123 | Nektar Therapeutics | NKTR | Jan 2026 | 5,150 | $192K | 0.52% | EC |
| 124 | Verastem Inc | VSTM | Jan 2026 | 29,315 | $179K | 0.49% | EC |
| 125 | Gossamer Bio Inc | GOSS | Jan 2026 | 78,256 | $178K | 0.49% | EC |
| 126 | Zenas Biopharma Inc | ZBIO | Jan 2026 | 6,941 | $128K | 0.35% | EC |
| 127 | Mereo Biopharma Group PLC | MREO | Jan 2026 | 129,828 | $57K | 0.16% | EC |